Psychology & Psychotherapy, 25(1), 19–30.
267
Tanya L Godwin, Hayward J Godwin, Laura M Simonds. What is the relationship between fear of self, self-ambivalence, and obsessive-compulsive symptomatology? A systematic literature review.
268
Summerfeldt LJS, Kloosterman PH, Antony MM and Swinson RP (2014). Examination of an obsessive-compulsive core dimensions model: structural validity of harm avoidance and incompleteness. Journal of Obsessive-Compulsive and Related Disorders 3, 83–94.
269
van den Hout, MA., van Dis, EA., van Woudenberg, C., and van de Groep, I. H. (2017). OCD-like checking in the lab: A meta-analysis and improvement of an experimental paradigm. Journal of Obsessive-Compulsive and Related Disorders 20, 39–49.
270
Dek ECP, van den Hout MA, Engelhard IM, Giele CL and Cath DC (2015). Perseveration causes automatization of checking behavior in obsessive-compulsive disorder. Behaviour Research and Therapy 71, 1–9.
271
Taylor J and Purdon C (2016). Responsibility and hand washing. Journal of Behavior Therapy and Experimental Psychiatry 51, 43–50.
272
https://news.mit.edu/2020/study-commercial-flights-safer-ever-0124.
273
Szechtman H and Woody E (2004). Obsessive-compulsive disorder as a disturbance of security motivation. Psychological Review 111, 111–127.
274
van Megen HJ, den Boer-Wolters D, Verhagen PJ (2010). "Obsessive compulsive disorder and religion: a reconnaissance". In Verhagen P, Van Praag HM, López-Ibor JJ Jr, Cox J, Moussaoui D (eds.). Religion and Psychiatry: Beyond Boundaries. Wiley, pp. 271–82.
275
Aho JA (2005). "Martin Luther and scrupulosity". Confession and Bookkeeping: the Religious, Moral, and Rhetorical Roots of Modern Accounting. Albany: State University of New York Press, pp. 95–8.
276
http://psylib.org.ua/books/kanny01/txt07.htm#3.
277
Минутко В. Навязчивые состояния. – Курск: ООО «ПЛАНЕТА +», 2011.
278
Davies M. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. Journal of Psychiatry and Neuroscience. 2003; 28(4): 263–274
279
https://www.thelancet.com/journals/lancet/article/PIIS0140–6736(09)60240–3/fulltext.
280
https://www.nature.com/articles/s41467–017–00831-x.
281
https://www.nature.com/articles/4001365.
282
Streptococcal Infections and Exacerbations in PANDAS: A Systеmatic Review and Meta-analysis. Nielsen MØ, Köhler-Forsberg O, Hjorthøj C, Benros ME, Nordentoft..
283
https://www.scielo.br/j/trends/a/kcDVrBpT6Bf3rh3B8Chnwcf/?format=pdf&lang=en.
284
McGrath MJ, Campbell KM, Parks CR, Burton FH. Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder. Brain Res. 2000; 15; 877: 23–30.
285
Anna M. Wehry, Katja Beesdo-Baum. Assessment and Treatment of Anxiety Disorders in Children and Adolescents. Curr Psychiatry Rep. 2015 Jul; 17(7): 591.
286
«Клинические рекомендации по лечению обсессивно-компульсивного расстройства» Американской психиатрической ассоциации (в переводе научного интернет-портала «Психиатрия & Нейронауки» и Клиники психиатрии «Доктор САН»).
287
Somnath Banerjee (2012). ADHD in Children and Adolescents: A Good Practice Guidance, Current Directions in ADHD and Its Treatment, Dr. Jill M. Norvilitis (Ed.).
288
Ratey NA. The Disorganized Mind, Coaching Your ADHD Brain to Take Control of Your Time, Tasks, and Talents. St. Martin's Press, 2008.
289
Hodgkins P, Arnold LE, Shaw M, et al. A Systematic Review of Global Publication Trends Regarding Long-Term Outcomes of ADHD. Frontiers in Psychiatry. 2011; 2: 84.
290
Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. Attention Deficit and Hyperactivity Disorders. 2010; 2(4): 241–255.
291
Ratey NA. The Disorganized Mind, Coaching Your ADHD Brain to Take Control of Your Time, Tasks, and Talents. St. Martin's Press, 2008.
292
Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. Attention Deficit and Hyperactivity Disorders. 2010; 2(4): 241–255
293
Strohl MP. Bradley's Benzedrine Studies on Children with Behavioral Disorders. The Yale Journal of Biology and Medicine. 2011; 84(1): 27–33
294
Myers RL. The 100 Most Important Chemical Compounds, A Reference Guide. ABC–CLIO; 2007: 178–80.
295
Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L. Financial ties between DSM – IV panel members and the pharmaceutical industry. Psychother Psychosom. 2006;75(3): 154–60
296
Americans With Disabilities Act of 1990, Pub. L. No. 101–336, 104 Stat. 328 (1990)
297
Kessler, R.C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M.J., Jin, R., Secnik, K., Spencer, T., Ustun, T.B., Walters, E.E. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS). Psychological Medicine, 35(2), 245–25
298
Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010; 10: 67
299
Arria AM, Wish ED. Nonmedical Use of Prescription Stimulants Among Students. Pediatric annals. 2006; 35(8): 565–571
300
Garnier-Dykstra LM, Caldeira KM, Vincent KB, O'Grady KE, Arria AM. Nonmedical use of prescription stimulants during college: Four-year trends in exposure opportunity, use, motives, and sources. Journal of American College Health: J of ACH. 2012; 60(3): 226–234
301
Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol. 2000; 10(4): 311–20
302
Faraone SV. Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths. P T. 2009; 34(12): 678–94
